Clinical trial

Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer Progression

NCT05426317

Study summary

ClinicalTrials.gov

Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer Progression

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

OTHER · Unmapped registry intervention Blood sample Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-02-10

PhaseNA

Conditions

Melanomaverified · MONDO: melanoma

Non Small Cell Lung Cancercandidate · MONDO: non-small cell lung carcinoma

Renal Cancerunresolved

Interventions

Blood sampleOTHER

Sponsors & collaborators

University Hospital, Clermont-Ferrandlead sponsor

Mapped research locations

Clermont-FerrandFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05426317 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.